Oppenheimer Adjusts Price Target for Spruce Biosciences Following Revenue Projection Update
Thursday, 13 June 2024, 10:18
Oppenheimer Adjusts Price Target
Reason: Revised Revenue Forecasts
- Oppenheimer has lowered the price target for Spruce Biosciences.
- This decision is based on the company's updated revenue forecasts.
- Accurate revenue projections are crucial in determining stock targets.
Investors should carefully consider the impact of these changes on their investment strategies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.